Related Experiment Videos
Bleeding complication during coumarin therapy due to amiodarone and azithromycin
The Journal of the Association of Physicians of India
|March 29, 2001
Summary
Drug interactions can be dangerous. Amiodarone and azithromycin increased bleeding risk in a patient with mechanical heart valves, leading to fatal heart failure despite anticoagulant reversal.
Area of Science:
- Pharmacology
- Cardiology
- Clinical Medicine
Background:
- Patients with mechanical heart valves often require anticoagulation therapy.
- Concurrent medication use necessitates careful evaluation for drug interactions.
Observation:
- A patient on anticoagulation therapy developed significant bleeding after initiating amiodarone and azithromycin.
- The bleeding was managed by neutralizing the anticoagulant effect.
Findings:
- The combination of amiodarone and azithromycin posed a significant bleeding risk in this patient.
- Despite intervention, the patient experienced a fatal outcome due to heart failure.
Implications:
- New medications prescribed to anticoagulated patients require thorough interaction assessment.
- Frequent prothrombin time monitoring is crucial for patients on anticoagulation and new drug therapies.